Skip to main content
TipRanks
Go Ultimate75% OFF

TherapeuticsMD (29TA) Stock Forecast & Price Target

3 Followers
See the Price Targets and Ratings of:

29TA Analyst Ratings

Currently, no data available

29TA Stock 12 Month Forecast

There Are No Analyst Ratings for 29TA In The Last 3 Months.

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for DE:29TA
Price TargetArticle
TipRanks - PerPlexity€1.81hold21.33%UpsideReiterated11/14/26
TipRanks - Google€1.81hold21.33%UpsideReiterated11/14/26
TipRanks - Anthropic€1.36→€1.81hold21.33%UpsideReiterated11/14/26
TipRanks - OpenAI€1.81hold21.33%UpsideReiterated11/14/26
TipRanks - DeepSeek€1.81hold21.33%UpsideReiterated11/14/26
TipRanks - xAI€1.81hold21.33%UpsideReiterated11/14/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
HROWHarrow Health
PLSEPulse Biosciences
DFTXDefinium Therapeutics
IMUXImmunic
MDWDMediwound

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

29TA Analyst Recommendation Trends

00.511.52Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for 29TA
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy00000
Buy00000
Hold00000
Sell00000
Strong Sell00000
total00000

In the current month, 29TA has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 29TA average Analyst price target in the past 3 months is ―.

29TA Financial Forecast

€-2€-1.25€-0.5€0.25€1Q4 2025Q2 2026Q3 2026
Consensus€0.01

29TA Earnings Forecast

Next quarter’s earnings estimate for 29TA is EUR 0.01 with a range of ― to ―. The previous quarter’s EPS was EUR 0.01. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

€654,443€692,634.8€730,826.5€769,018.3€807,210Q4 2025Q2 2026Q3 2026
Consensus€786K

29TA Sales Forecast

Next quarter’s sales forecast for 29TA is EUR 785.51K with a range of ― to ―. The previous quarter’s sales results were EUR 785.51K. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

29TA Stock Forecast FAQ

Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
What do analysts say about TherapeuticsMD?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of TherapeuticsMD?
To buy shares of DE:29TA, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.